Profund Advisors LLC lifted its position in CME Group Inc (NASDAQ:CME) by 54.6% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 9,143 shares of the financial services provider’s stock after buying an additional 3,229 shares during the period. Profund Advisors LLC’s holdings in CME Group were worth $1,775,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds have also recently added to or reduced their stakes in the company. Close Asset Management Ltd purchased a new position in shares of CME Group in the 1st quarter worth $34,000. Advantage Investment Management LLC lifted its position in CME Group by 119.0% during the second quarter. Advantage Investment Management LLC now owns 184 shares of the financial services provider’s stock valued at $36,000 after purchasing an additional 100 shares in the last quarter. Westside Investment Management Inc. purchased a new position in CME Group during the second quarter valued at $38,000. Permanens Capital L.P. purchased a new position in CME Group during the first quarter valued at $41,000. Finally, Motco lifted its position in CME Group by 55.8% during the second quarter. Motco now owns 268 shares of the financial services provider’s stock valued at $52,000 after purchasing an additional 96 shares in the last quarter. Hedge funds and other institutional investors own 84.99% of the company’s stock.
In other CME Group news, CEO Terrence A. Duffy sold 35,000 shares of the firm’s stock in a transaction dated Thursday, August 1st. The stock was sold at an average price of $200.15, for a total transaction of $7,005,250.00. Following the sale, the chief executive officer now directly owns 79,057 shares of the company’s stock, valued at $15,823,258.55. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, insider Sean Tully sold 7,200 shares of the firm’s stock in a transaction dated Friday, September 6th. The shares were sold at an average price of $223.13, for a total value of $1,606,536.00. Following the sale, the insider now directly owns 19,923 shares in the company, valued at $4,445,418.99. The disclosure for this sale can be found here. Over the last three months, insiders have sold 59,626 shares of company stock worth $12,255,934. Insiders own 1.20% of the company’s stock.
NASDAQ:CME traded up $0.42 on Friday, reaching $205.80. 974,804 shares of the company’s stock traded hands, compared to its average volume of 1,132,937. The company has a quick ratio of 1.05, a current ratio of 1.05 and a debt-to-equity ratio of 0.15. The stock has a 50-day simple moving average of $211.25 and a 200-day simple moving average of $191.16. The firm has a market cap of $72.54 billion, a PE ratio of 30.18, a P/E/G ratio of 4.51 and a beta of 0.19. CME Group Inc has a 12 month low of $161.05 and a 12 month high of $224.91.
CME Group (NASDAQ:CME) last posted its quarterly earnings results on Wednesday, July 31st. The financial services provider reported $1.76 EPS for the quarter, beating the Zacks’ consensus estimate of $1.75 by $0.01. The business had revenue of $1.27 billion for the quarter, compared to analysts’ expectations of $1.27 billion. CME Group had a return on equity of 9.14% and a net margin of 39.36%. The business’s quarterly revenue was up 20.1% on a year-over-year basis. During the same period last year, the firm earned $1.74 earnings per share. On average, equities analysts anticipate that CME Group Inc will post 6.69 earnings per share for the current year.
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 25th. Shareholders of record on Tuesday, September 10th will be issued a dividend of $0.75 per share. The ex-dividend date of this dividend is Monday, September 9th. This represents a $3.00 dividend on an annualized basis and a yield of 1.46%. CME Group’s dividend payout ratio is presently 43.99%.
CME has been the topic of several analyst reports. Deutsche Bank lifted their target price on CME Group from $224.00 to $240.00 and gave the company a “buy” rating in a research report on Friday, August 9th. Barclays lifted their target price on CME Group from $191.00 to $197.00 and gave the company an “overweight” rating in a research report on Thursday, May 23rd. Zacks Investment Research downgraded CME Group from a “hold” rating to a “sell” rating and set a $158.00 target price on the stock. in a research report on Monday, May 27th. UBS Group lifted their target price on CME Group from $191.00 to $214.00 and gave the company a “neutral” rating in a research report on Thursday, September 5th. Finally, Wells Fargo & Co lifted their target price on CME Group from $176.00 to $200.00 and gave the company a “market perform” rating in a research report on Wednesday, July 3rd. Three analysts have rated the stock with a sell rating, six have issued a hold rating and seven have given a buy rating to the company’s stock. The stock has an average rating of “Hold” and an average target price of $196.85.
CME Group Profile
CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.
Further Reading: Short Selling Stocks and Day Traders
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc (NASDAQ:CME).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.